Convertible Note - SyntheX
Investment Firm
Overview
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Announced Date
Jul 27, 2022
Closed on Date
Jul 27, 2022
Funding Type
Convertible Note
Highlights
Location
United States, North America
Social
Round Details and Background
SyntheX raised an undisclosed amount on 2022-07-27 in Convertible Note
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 27, 2022 |  Convertible Note - SyntheX | 2 | - | undefined |
| Dec 29, 2023 | Venture Round - SyntheX | - | 5.2M | |
| Mar 01, 2017 | Seed Round - SyntheX | 4 | - | 6.2M |
| Mar 10, 2016 | Convertible Note - SyntheX | 2 | - | 250.0K |
Recent Activity
There is no recent news or activity for this profile.